Latest filing published 22 Jan 2021 for Calithera Biosciences, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Curtis Hecht: trading record in brief
Curtis Hecht discloses dealings in Calithera Biosciences, Inc. to SEC (Form 4). In total, 9 filings cover trades dated from 20 August 2015 to 20 January 2021.
Every open-market trade on record is a sale: 5 sales worth €40k. Other entries cover 2 share grants and 1 option exercise.
The newest entry dates from 22 January 2021: a share grant, in Calithera Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Curtis Hecht
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,000 shares0Common StockSEC:0000899243-21-003055:0
- 30,000 shares0Common StockSEC:0000899243-21-003055:1
- 700 shares@ US$18.00Common StockSEC:0000899243-17-018069:0
- 650 shares@ US$16.00Common StockSEC:0000899243-17-014121:0
- 600 shares@ US$14.00Common StockSEC:0000899243-17-007609:0
- 550 shares@ US$12.00Common StockSEC:0000899243-17-006590:0
- 3,085 shares0Common StockSEC:0000899243-16-026746:0
- 970 shares@ US$6.58Common StockSEC:0001209191-15-081122:0
- 2,000 shares@ US$2.64Common StockSEC:0001209191-15-067578:0
9 of 9 declarations
